Activation of Siglec-7 results in inhibition of in vitro and in vivo growth of human mast cell leukemia cells.
Landolina N, Zaffran I, Smiljkovic D, Serrano-Candelas E, Schmiedel D, Friedman S, Arock M, Hartmann K, Pikarsky E, Mandelboim O, Martin M, Valent P, Levi-Schaffer F.
Landolina N, et al. Among authors: pikarsky e.
Pharmacol Res. 2020 Aug;158:104682. doi: 10.1016/j.phrs.2020.104682. Epub 2020 Feb 5.
Pharmacol Res. 2020.
PMID: 32035162
Free article.